Table 19. Higher education R&D expenditures for clinical trials, by source of funds, highest degree granted, and institutional control: FY 2012 |
(Dollars in thousands) |
All sources | Federal | Nonfederal | |||||
---|---|---|---|---|---|---|---|
Type of institution | Institutions with clinical trials expenditures (n) |
All R&D expenditures |
Clinical trials | All R&D expenditures |
Clinical trials | All R&D expenditures |
Clinical trials |
All institutions | 165 | 46,211,769 | 1,698,948 | 28,944,296 | 654,218 | 17,267,473 | 1,044,730 |
Doctorate | 149 | 46,109,230 | 1,690,476 | 28,886,124 | 647,010 | 17,223,106 | 1,043,466 |
Nondoctorate | 16 | 102,539 | 8,472 | 58,172 | 7,208 | 44,367 | 1,264 |
Public | 95 | 28,987,962 | 603,378 | 16,766,162 | 193,338 | 12,221,800 | 410,040 |
Private | 70 | 17,223,807 | 1,095,570 | 12,178,134 | 460,880 | 5,045,673 | 634,690 |
SOURCE: National Science Foundation, National Center for Science and Engineering Statistics, Higher Education Research and Development Survey, FY 2012. |
Data from survey cycle FY 2012, as of 30 October 2013. |